ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in Point72 (DIFC) Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2024 Q1)
Avg. % of fund
0.02%
First filed
2024 Q1
Last filed
2025 Q2
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 9,764 +5,539 +131.1% 0.01% $211K $21.57
2025 Q1 REDUCED 4,225 -39,370 -90.3% 0.00% $70K $16.61
2024 Q4 ADDED 43,595 +42,363 +3438.6% 0.03% $800K $18.35
2024 Q2 REDUCED 1,232 -76,131 -98.4% 0.00% $20K $16.25
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ACAD price (monthly, adj. close)

Other funds also holding ACAD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.24% BAKER BROS. ADVISORS LP 3Y 7Y 6.71% Birchview Capital, LP 3Y 7Y 2.67% Nan Fung Group Holdings Ltd 3Y 2.46% Axecap Investments, LLC 2.25% Stonepine Capital Management, LLC 3Y 7Y 1.95% RTW INVESTMENTS, LP 3Y 7Y 1.91% BRAIDWELL LP 3Y 1.74% Logos Global Management LP 3Y 1.37% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.1%
← Back to Point72 (DIFC) Ltd Holdings